Global CD20 Target Drug Supply, Demand and Key Producers, 2023-2029
The global CD20 Target Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
CD20 is a cell surface antigen that usually appears on the surface of B lymphocytes. CD20-targeted drugs are a class of drugs used to treat specific types of B cell-related diseases. These drugs affect the survival and function of B cells by targeting the CD20 antigen. These drugs are primarily used to treat B-cell lymphoma and autoimmune diseases.
This report studies the global CD20 Target Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD20 Target Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD20 Target Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD20 Target Drug total production and demand, 2018-2029, (K Units)
Global CD20 Target Drug total production value, 2018-2029, (USD Million)
Global CD20 Target Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CD20 Target Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: CD20 Target Drug domestic production, consumption, key domestic manufacturers and share
Global CD20 Target Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global CD20 Target Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CD20 Target Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global CD20 Target Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Sanofi, Novartis, TG Therapeutics, AbbVie, Genmab, PT Kalbe Genexine Biologics, Amgen, Inc. and Pfizer Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD20 Target Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD20 Target Drug Market, By Region:
1. How big is the global CD20 Target Drug market?
2. What is the demand of the global CD20 Target Drug market?
3. What is the year over year growth of the global CD20 Target Drug market?
4. What is the production and production value of the global CD20 Target Drug market?
5. Who are the key producers in the global CD20 Target Drug market?
CD20 is a cell surface antigen that usually appears on the surface of B lymphocytes. CD20-targeted drugs are a class of drugs used to treat specific types of B cell-related diseases. These drugs affect the survival and function of B cells by targeting the CD20 antigen. These drugs are primarily used to treat B-cell lymphoma and autoimmune diseases.
This report studies the global CD20 Target Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD20 Target Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD20 Target Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD20 Target Drug total production and demand, 2018-2029, (K Units)
Global CD20 Target Drug total production value, 2018-2029, (USD Million)
Global CD20 Target Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CD20 Target Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: CD20 Target Drug domestic production, consumption, key domestic manufacturers and share
Global CD20 Target Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global CD20 Target Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CD20 Target Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global CD20 Target Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Sanofi, Novartis, TG Therapeutics, AbbVie, Genmab, PT Kalbe Genexine Biologics, Amgen, Inc. and Pfizer Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD20 Target Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD20 Target Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CD20 Target
- CD20+CD3 Target
- Rheumatoid Arthritis
- Chronic Lymphocytic Leukemia
- Lymphoma
- Other
- Roche
- Sanofi
- Novartis
- TG Therapeutics
- AbbVie
- Genmab
- PT Kalbe Genexine Biologics
- Amgen, Inc.
- Pfizer Inc.
- Sandoz, Inc.
- Celltrion, Inc.
- Biocad Medical, Inc.
- mAbxience SA
- Hetero Drugs Ltd.
- Aryogen Pharmed
- Biosidus SA
- Probiomed SA de CV
- Henlius
- Innovent
- CHIATAI TIANOING
- CASI Pharmaceuticals
- SinoCellTech
- BioRay
1. How big is the global CD20 Target Drug market?
2. What is the demand of the global CD20 Target Drug market?
3. What is the year over year growth of the global CD20 Target Drug market?
4. What is the production and production value of the global CD20 Target Drug market?
5. Who are the key producers in the global CD20 Target Drug market?
1 SUPPLY SUMMARY
1.1 CD20 Target Drug Introduction
1.2 World CD20 Target Drug Supply & Forecast
1.2.1 World CD20 Target Drug Production Value (2018 & 2022 & 2029)
1.2.2 World CD20 Target Drug Production (2018-2029)
1.2.3 World CD20 Target Drug Pricing Trends (2018-2029)
1.3 World CD20 Target Drug Production by Region (Based on Production Site)
1.3.1 World CD20 Target Drug Production Value by Region (2018-2029)
1.3.2 World CD20 Target Drug Production by Region (2018-2029)
1.3.3 World CD20 Target Drug Average Price by Region (2018-2029)
1.3.4 North America CD20 Target Drug Production (2018-2029)
1.3.5 Europe CD20 Target Drug Production (2018-2029)
1.3.6 China CD20 Target Drug Production (2018-2029)
1.3.7 Japan CD20 Target Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD20 Target Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD20 Target Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World CD20 Target Drug Demand (2018-2029)
2.2 World CD20 Target Drug Consumption by Region
2.2.1 World CD20 Target Drug Consumption by Region (2018-2023)
2.2.2 World CD20 Target Drug Consumption Forecast by Region (2024-2029)
2.3 United States CD20 Target Drug Consumption (2018-2029)
2.4 China CD20 Target Drug Consumption (2018-2029)
2.5 Europe CD20 Target Drug Consumption (2018-2029)
2.6 Japan CD20 Target Drug Consumption (2018-2029)
2.7 South Korea CD20 Target Drug Consumption (2018-2029)
2.8 ASEAN CD20 Target Drug Consumption (2018-2029)
2.9 India CD20 Target Drug Consumption (2018-2029)
3 WORLD CD20 TARGET DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CD20 Target Drug Production Value by Manufacturer (2018-2023)
3.2 World CD20 Target Drug Production by Manufacturer (2018-2023)
3.3 World CD20 Target Drug Average Price by Manufacturer (2018-2023)
3.4 CD20 Target Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CD20 Target Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CD20 Target Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for CD20 Target Drug in 2022
3.6 CD20 Target Drug Market: Overall Company Footprint Analysis
3.6.1 CD20 Target Drug Market: Region Footprint
3.6.2 CD20 Target Drug Market: Company Product Type Footprint
3.6.3 CD20 Target Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CD20 Target Drug Production Value Comparison
4.1.1 United States VS China: CD20 Target Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CD20 Target Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CD20 Target Drug Production Comparison
4.2.1 United States VS China: CD20 Target Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD20 Target Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CD20 Target Drug Consumption Comparison
4.3.1 United States VS China: CD20 Target Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CD20 Target Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CD20 Target Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CD20 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CD20 Target Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers CD20 Target Drug Production (2018-2023)
4.5 China Based CD20 Target Drug Manufacturers and Market Share
4.5.1 China Based CD20 Target Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CD20 Target Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers CD20 Target Drug Production (2018-2023)
4.6 Rest of World Based CD20 Target Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CD20 Target Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CD20 Target Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CD20 Target Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD20 Target Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD20 Target
5.2.2 CD20+CD3 Target
5.3 Market Segment by Type
5.3.1 World CD20 Target Drug Production by Type (2018-2029)
5.3.2 World CD20 Target Drug Production Value by Type (2018-2029)
5.3.3 World CD20 Target Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD20 Target Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Rheumatoid Arthritis
6.2.2 Chronic Lymphocytic Leukemia
6.2.3 Lymphoma
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World CD20 Target Drug Production by Application (2018-2029)
6.3.2 World CD20 Target Drug Production Value by Application (2018-2029)
6.3.3 World CD20 Target Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche CD20 Target Drug Product and Services
7.1.4 Roche CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi CD20 Target Drug Product and Services
7.2.4 Sanofi CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis CD20 Target Drug Product and Services
7.3.4 Novartis CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 TG Therapeutics
7.4.1 TG Therapeutics Details
7.4.2 TG Therapeutics Major Business
7.4.3 TG Therapeutics CD20 Target Drug Product and Services
7.4.4 TG Therapeutics CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 TG Therapeutics Recent Developments/Updates
7.4.6 TG Therapeutics Competitive Strengths & Weaknesses
7.5 AbbVie
7.5.1 AbbVie Details
7.5.2 AbbVie Major Business
7.5.3 AbbVie CD20 Target Drug Product and Services
7.5.4 AbbVie CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AbbVie Recent Developments/Updates
7.5.6 AbbVie Competitive Strengths & Weaknesses
7.6 Genmab
7.6.1 Genmab Details
7.6.2 Genmab Major Business
7.6.3 Genmab CD20 Target Drug Product and Services
7.6.4 Genmab CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Genmab Recent Developments/Updates
7.6.6 Genmab Competitive Strengths & Weaknesses
7.7 PT Kalbe Genexine Biologics
7.7.1 PT Kalbe Genexine Biologics Details
7.7.2 PT Kalbe Genexine Biologics Major Business
7.7.3 PT Kalbe Genexine Biologics CD20 Target Drug Product and Services
7.7.4 PT Kalbe Genexine Biologics CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 PT Kalbe Genexine Biologics Recent Developments/Updates
7.7.6 PT Kalbe Genexine Biologics Competitive Strengths & Weaknesses
7.8 Amgen, Inc.
7.8.1 Amgen, Inc. Details
7.8.2 Amgen, Inc. Major Business
7.8.3 Amgen, Inc. CD20 Target Drug Product and Services
7.8.4 Amgen, Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Amgen, Inc. Recent Developments/Updates
7.8.6 Amgen, Inc. Competitive Strengths & Weaknesses
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Details
7.9.2 Pfizer Inc. Major Business
7.9.3 Pfizer Inc. CD20 Target Drug Product and Services
7.9.4 Pfizer Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Pfizer Inc. Recent Developments/Updates
7.9.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.10 Sandoz, Inc.
7.10.1 Sandoz, Inc. Details
7.10.2 Sandoz, Inc. Major Business
7.10.3 Sandoz, Inc. CD20 Target Drug Product and Services
7.10.4 Sandoz, Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sandoz, Inc. Recent Developments/Updates
7.10.6 Sandoz, Inc. Competitive Strengths & Weaknesses
7.11 Celltrion, Inc.
7.11.1 Celltrion, Inc. Details
7.11.2 Celltrion, Inc. Major Business
7.11.3 Celltrion, Inc. CD20 Target Drug Product and Services
7.11.4 Celltrion, Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Celltrion, Inc. Recent Developments/Updates
7.11.6 Celltrion, Inc. Competitive Strengths & Weaknesses
7.12 Biocad Medical, Inc.
7.12.1 Biocad Medical, Inc. Details
7.12.2 Biocad Medical, Inc. Major Business
7.12.3 Biocad Medical, Inc. CD20 Target Drug Product and Services
7.12.4 Biocad Medical, Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Biocad Medical, Inc. Recent Developments/Updates
7.12.6 Biocad Medical, Inc. Competitive Strengths & Weaknesses
7.13 mAbxience SA
7.13.1 mAbxience SA Details
7.13.2 mAbxience SA Major Business
7.13.3 mAbxience SA CD20 Target Drug Product and Services
7.13.4 mAbxience SA CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 mAbxience SA Recent Developments/Updates
7.13.6 mAbxience SA Competitive Strengths & Weaknesses
7.14 Hetero Drugs Ltd.
7.14.1 Hetero Drugs Ltd. Details
7.14.2 Hetero Drugs Ltd. Major Business
7.14.3 Hetero Drugs Ltd. CD20 Target Drug Product and Services
7.14.4 Hetero Drugs Ltd. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Hetero Drugs Ltd. Recent Developments/Updates
7.14.6 Hetero Drugs Ltd. Competitive Strengths & Weaknesses
7.15 Aryogen Pharmed
7.15.1 Aryogen Pharmed Details
7.15.2 Aryogen Pharmed Major Business
7.15.3 Aryogen Pharmed CD20 Target Drug Product and Services
7.15.4 Aryogen Pharmed CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Aryogen Pharmed Recent Developments/Updates
7.15.6 Aryogen Pharmed Competitive Strengths & Weaknesses
7.16 Biosidus SA
7.16.1 Biosidus SA Details
7.16.2 Biosidus SA Major Business
7.16.3 Biosidus SA CD20 Target Drug Product and Services
7.16.4 Biosidus SA CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Biosidus SA Recent Developments/Updates
7.16.6 Biosidus SA Competitive Strengths & Weaknesses
7.17 Probiomed SA de CV
7.17.1 Probiomed SA de CV Details
7.17.2 Probiomed SA de CV Major Business
7.17.3 Probiomed SA de CV CD20 Target Drug Product and Services
7.17.4 Probiomed SA de CV CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Probiomed SA de CV Recent Developments/Updates
7.17.6 Probiomed SA de CV Competitive Strengths & Weaknesses
7.18 Henlius
7.18.1 Henlius Details
7.18.2 Henlius Major Business
7.18.3 Henlius CD20 Target Drug Product and Services
7.18.4 Henlius CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Henlius Recent Developments/Updates
7.18.6 Henlius Competitive Strengths & Weaknesses
7.19 Innovent
7.19.1 Innovent Details
7.19.2 Innovent Major Business
7.19.3 Innovent CD20 Target Drug Product and Services
7.19.4 Innovent CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Innovent Recent Developments/Updates
7.19.6 Innovent Competitive Strengths & Weaknesses
7.20 CHIATAI TIANOING
7.20.1 CHIATAI TIANOING Details
7.20.2 CHIATAI TIANOING Major Business
7.20.3 CHIATAI TIANOING CD20 Target Drug Product and Services
7.20.4 CHIATAI TIANOING CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 CHIATAI TIANOING Recent Developments/Updates
7.20.6 CHIATAI TIANOING Competitive Strengths & Weaknesses
7.21 CASI Pharmaceuticals
7.21.1 CASI Pharmaceuticals Details
7.21.2 CASI Pharmaceuticals Major Business
7.21.3 CASI Pharmaceuticals CD20 Target Drug Product and Services
7.21.4 CASI Pharmaceuticals CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 CASI Pharmaceuticals Recent Developments/Updates
7.21.6 CASI Pharmaceuticals Competitive Strengths & Weaknesses
7.22 SinoCellTech
7.22.1 SinoCellTech Details
7.22.2 SinoCellTech Major Business
7.22.3 SinoCellTech CD20 Target Drug Product and Services
7.22.4 SinoCellTech CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 SinoCellTech Recent Developments/Updates
7.22.6 SinoCellTech Competitive Strengths & Weaknesses
7.23 BioRay
7.23.1 BioRay Details
7.23.2 BioRay Major Business
7.23.3 BioRay CD20 Target Drug Product and Services
7.23.4 BioRay CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 BioRay Recent Developments/Updates
7.23.6 BioRay Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD20 Target Drug Industry Chain
8.2 CD20 Target Drug Upstream Analysis
8.2.1 CD20 Target Drug Core Raw Materials
8.2.2 Main Manufacturers of CD20 Target Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CD20 Target Drug Production Mode
8.6 CD20 Target Drug Procurement Model
8.7 CD20 Target Drug Industry Sales Model and Sales Channels
8.7.1 CD20 Target Drug Sales Model
8.7.2 CD20 Target Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CD20 Target Drug Introduction
1.2 World CD20 Target Drug Supply & Forecast
1.2.1 World CD20 Target Drug Production Value (2018 & 2022 & 2029)
1.2.2 World CD20 Target Drug Production (2018-2029)
1.2.3 World CD20 Target Drug Pricing Trends (2018-2029)
1.3 World CD20 Target Drug Production by Region (Based on Production Site)
1.3.1 World CD20 Target Drug Production Value by Region (2018-2029)
1.3.2 World CD20 Target Drug Production by Region (2018-2029)
1.3.3 World CD20 Target Drug Average Price by Region (2018-2029)
1.3.4 North America CD20 Target Drug Production (2018-2029)
1.3.5 Europe CD20 Target Drug Production (2018-2029)
1.3.6 China CD20 Target Drug Production (2018-2029)
1.3.7 Japan CD20 Target Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD20 Target Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD20 Target Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World CD20 Target Drug Demand (2018-2029)
2.2 World CD20 Target Drug Consumption by Region
2.2.1 World CD20 Target Drug Consumption by Region (2018-2023)
2.2.2 World CD20 Target Drug Consumption Forecast by Region (2024-2029)
2.3 United States CD20 Target Drug Consumption (2018-2029)
2.4 China CD20 Target Drug Consumption (2018-2029)
2.5 Europe CD20 Target Drug Consumption (2018-2029)
2.6 Japan CD20 Target Drug Consumption (2018-2029)
2.7 South Korea CD20 Target Drug Consumption (2018-2029)
2.8 ASEAN CD20 Target Drug Consumption (2018-2029)
2.9 India CD20 Target Drug Consumption (2018-2029)
3 WORLD CD20 TARGET DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CD20 Target Drug Production Value by Manufacturer (2018-2023)
3.2 World CD20 Target Drug Production by Manufacturer (2018-2023)
3.3 World CD20 Target Drug Average Price by Manufacturer (2018-2023)
3.4 CD20 Target Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CD20 Target Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CD20 Target Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for CD20 Target Drug in 2022
3.6 CD20 Target Drug Market: Overall Company Footprint Analysis
3.6.1 CD20 Target Drug Market: Region Footprint
3.6.2 CD20 Target Drug Market: Company Product Type Footprint
3.6.3 CD20 Target Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CD20 Target Drug Production Value Comparison
4.1.1 United States VS China: CD20 Target Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CD20 Target Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CD20 Target Drug Production Comparison
4.2.1 United States VS China: CD20 Target Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD20 Target Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CD20 Target Drug Consumption Comparison
4.3.1 United States VS China: CD20 Target Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CD20 Target Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CD20 Target Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CD20 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CD20 Target Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers CD20 Target Drug Production (2018-2023)
4.5 China Based CD20 Target Drug Manufacturers and Market Share
4.5.1 China Based CD20 Target Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CD20 Target Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers CD20 Target Drug Production (2018-2023)
4.6 Rest of World Based CD20 Target Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CD20 Target Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CD20 Target Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CD20 Target Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD20 Target Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD20 Target
5.2.2 CD20+CD3 Target
5.3 Market Segment by Type
5.3.1 World CD20 Target Drug Production by Type (2018-2029)
5.3.2 World CD20 Target Drug Production Value by Type (2018-2029)
5.3.3 World CD20 Target Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD20 Target Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Rheumatoid Arthritis
6.2.2 Chronic Lymphocytic Leukemia
6.2.3 Lymphoma
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World CD20 Target Drug Production by Application (2018-2029)
6.3.2 World CD20 Target Drug Production Value by Application (2018-2029)
6.3.3 World CD20 Target Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche CD20 Target Drug Product and Services
7.1.4 Roche CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi CD20 Target Drug Product and Services
7.2.4 Sanofi CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis CD20 Target Drug Product and Services
7.3.4 Novartis CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 TG Therapeutics
7.4.1 TG Therapeutics Details
7.4.2 TG Therapeutics Major Business
7.4.3 TG Therapeutics CD20 Target Drug Product and Services
7.4.4 TG Therapeutics CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 TG Therapeutics Recent Developments/Updates
7.4.6 TG Therapeutics Competitive Strengths & Weaknesses
7.5 AbbVie
7.5.1 AbbVie Details
7.5.2 AbbVie Major Business
7.5.3 AbbVie CD20 Target Drug Product and Services
7.5.4 AbbVie CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AbbVie Recent Developments/Updates
7.5.6 AbbVie Competitive Strengths & Weaknesses
7.6 Genmab
7.6.1 Genmab Details
7.6.2 Genmab Major Business
7.6.3 Genmab CD20 Target Drug Product and Services
7.6.4 Genmab CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Genmab Recent Developments/Updates
7.6.6 Genmab Competitive Strengths & Weaknesses
7.7 PT Kalbe Genexine Biologics
7.7.1 PT Kalbe Genexine Biologics Details
7.7.2 PT Kalbe Genexine Biologics Major Business
7.7.3 PT Kalbe Genexine Biologics CD20 Target Drug Product and Services
7.7.4 PT Kalbe Genexine Biologics CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 PT Kalbe Genexine Biologics Recent Developments/Updates
7.7.6 PT Kalbe Genexine Biologics Competitive Strengths & Weaknesses
7.8 Amgen, Inc.
7.8.1 Amgen, Inc. Details
7.8.2 Amgen, Inc. Major Business
7.8.3 Amgen, Inc. CD20 Target Drug Product and Services
7.8.4 Amgen, Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Amgen, Inc. Recent Developments/Updates
7.8.6 Amgen, Inc. Competitive Strengths & Weaknesses
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Details
7.9.2 Pfizer Inc. Major Business
7.9.3 Pfizer Inc. CD20 Target Drug Product and Services
7.9.4 Pfizer Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Pfizer Inc. Recent Developments/Updates
7.9.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.10 Sandoz, Inc.
7.10.1 Sandoz, Inc. Details
7.10.2 Sandoz, Inc. Major Business
7.10.3 Sandoz, Inc. CD20 Target Drug Product and Services
7.10.4 Sandoz, Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sandoz, Inc. Recent Developments/Updates
7.10.6 Sandoz, Inc. Competitive Strengths & Weaknesses
7.11 Celltrion, Inc.
7.11.1 Celltrion, Inc. Details
7.11.2 Celltrion, Inc. Major Business
7.11.3 Celltrion, Inc. CD20 Target Drug Product and Services
7.11.4 Celltrion, Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Celltrion, Inc. Recent Developments/Updates
7.11.6 Celltrion, Inc. Competitive Strengths & Weaknesses
7.12 Biocad Medical, Inc.
7.12.1 Biocad Medical, Inc. Details
7.12.2 Biocad Medical, Inc. Major Business
7.12.3 Biocad Medical, Inc. CD20 Target Drug Product and Services
7.12.4 Biocad Medical, Inc. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Biocad Medical, Inc. Recent Developments/Updates
7.12.6 Biocad Medical, Inc. Competitive Strengths & Weaknesses
7.13 mAbxience SA
7.13.1 mAbxience SA Details
7.13.2 mAbxience SA Major Business
7.13.3 mAbxience SA CD20 Target Drug Product and Services
7.13.4 mAbxience SA CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 mAbxience SA Recent Developments/Updates
7.13.6 mAbxience SA Competitive Strengths & Weaknesses
7.14 Hetero Drugs Ltd.
7.14.1 Hetero Drugs Ltd. Details
7.14.2 Hetero Drugs Ltd. Major Business
7.14.3 Hetero Drugs Ltd. CD20 Target Drug Product and Services
7.14.4 Hetero Drugs Ltd. CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Hetero Drugs Ltd. Recent Developments/Updates
7.14.6 Hetero Drugs Ltd. Competitive Strengths & Weaknesses
7.15 Aryogen Pharmed
7.15.1 Aryogen Pharmed Details
7.15.2 Aryogen Pharmed Major Business
7.15.3 Aryogen Pharmed CD20 Target Drug Product and Services
7.15.4 Aryogen Pharmed CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Aryogen Pharmed Recent Developments/Updates
7.15.6 Aryogen Pharmed Competitive Strengths & Weaknesses
7.16 Biosidus SA
7.16.1 Biosidus SA Details
7.16.2 Biosidus SA Major Business
7.16.3 Biosidus SA CD20 Target Drug Product and Services
7.16.4 Biosidus SA CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Biosidus SA Recent Developments/Updates
7.16.6 Biosidus SA Competitive Strengths & Weaknesses
7.17 Probiomed SA de CV
7.17.1 Probiomed SA de CV Details
7.17.2 Probiomed SA de CV Major Business
7.17.3 Probiomed SA de CV CD20 Target Drug Product and Services
7.17.4 Probiomed SA de CV CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Probiomed SA de CV Recent Developments/Updates
7.17.6 Probiomed SA de CV Competitive Strengths & Weaknesses
7.18 Henlius
7.18.1 Henlius Details
7.18.2 Henlius Major Business
7.18.3 Henlius CD20 Target Drug Product and Services
7.18.4 Henlius CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Henlius Recent Developments/Updates
7.18.6 Henlius Competitive Strengths & Weaknesses
7.19 Innovent
7.19.1 Innovent Details
7.19.2 Innovent Major Business
7.19.3 Innovent CD20 Target Drug Product and Services
7.19.4 Innovent CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Innovent Recent Developments/Updates
7.19.6 Innovent Competitive Strengths & Weaknesses
7.20 CHIATAI TIANOING
7.20.1 CHIATAI TIANOING Details
7.20.2 CHIATAI TIANOING Major Business
7.20.3 CHIATAI TIANOING CD20 Target Drug Product and Services
7.20.4 CHIATAI TIANOING CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 CHIATAI TIANOING Recent Developments/Updates
7.20.6 CHIATAI TIANOING Competitive Strengths & Weaknesses
7.21 CASI Pharmaceuticals
7.21.1 CASI Pharmaceuticals Details
7.21.2 CASI Pharmaceuticals Major Business
7.21.3 CASI Pharmaceuticals CD20 Target Drug Product and Services
7.21.4 CASI Pharmaceuticals CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 CASI Pharmaceuticals Recent Developments/Updates
7.21.6 CASI Pharmaceuticals Competitive Strengths & Weaknesses
7.22 SinoCellTech
7.22.1 SinoCellTech Details
7.22.2 SinoCellTech Major Business
7.22.3 SinoCellTech CD20 Target Drug Product and Services
7.22.4 SinoCellTech CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 SinoCellTech Recent Developments/Updates
7.22.6 SinoCellTech Competitive Strengths & Weaknesses
7.23 BioRay
7.23.1 BioRay Details
7.23.2 BioRay Major Business
7.23.3 BioRay CD20 Target Drug Product and Services
7.23.4 BioRay CD20 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 BioRay Recent Developments/Updates
7.23.6 BioRay Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD20 Target Drug Industry Chain
8.2 CD20 Target Drug Upstream Analysis
8.2.1 CD20 Target Drug Core Raw Materials
8.2.2 Main Manufacturers of CD20 Target Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CD20 Target Drug Production Mode
8.6 CD20 Target Drug Procurement Model
8.7 CD20 Target Drug Industry Sales Model and Sales Channels
8.7.1 CD20 Target Drug Sales Model
8.7.2 CD20 Target Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CD20 Target Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CD20 Target Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World CD20 Target Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World CD20 Target Drug Production Value Market Share by Region (2018-2023)
Table 5. World CD20 Target Drug Production Value Market Share by Region (2024-2029)
Table 6. World CD20 Target Drug Production by Region (2018-2023) & (K Units)
Table 7. World CD20 Target Drug Production by Region (2024-2029) & (K Units)
Table 8. World CD20 Target Drug Production Market Share by Region (2018-2023)
Table 9. World CD20 Target Drug Production Market Share by Region (2024-2029)
Table 10. World CD20 Target Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World CD20 Target Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. CD20 Target Drug Major Market Trends
Table 13. World CD20 Target Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World CD20 Target Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World CD20 Target Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World CD20 Target Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CD20 Target Drug Producers in 2022
Table 18. World CD20 Target Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key CD20 Target Drug Producers in 2022
Table 20. World CD20 Target Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global CD20 Target Drug Company Evaluation Quadrant
Table 22. World CD20 Target Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CD20 Target Drug Production Site of Key Manufacturer
Table 24. CD20 Target Drug Market: Company Product Type Footprint
Table 25. CD20 Target Drug Market: Company Product Application Footprint
Table 26. CD20 Target Drug Competitive Factors
Table 27. CD20 Target Drug New Entrant and Capacity Expansion Plans
Table 28. CD20 Target Drug Mergers & Acquisitions Activity
Table 29. United States VS China CD20 Target Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CD20 Target Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China CD20 Target Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based CD20 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CD20 Target Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CD20 Target Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CD20 Target Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers CD20 Target Drug Production Market Share (2018-2023)
Table 37. China Based CD20 Target Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CD20 Target Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CD20 Target Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CD20 Target Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers CD20 Target Drug Production Market Share (2018-2023)
Table 42. Rest of World Based CD20 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CD20 Target Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CD20 Target Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CD20 Target Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers CD20 Target Drug Production Market Share (2018-2023)
Table 47. World CD20 Target Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CD20 Target Drug Production by Type (2018-2023) & (K Units)
Table 49. World CD20 Target Drug Production by Type (2024-2029) & (K Units)
Table 50. World CD20 Target Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World CD20 Target Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World CD20 Target Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World CD20 Target Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World CD20 Target Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CD20 Target Drug Production by Application (2018-2023) & (K Units)
Table 56. World CD20 Target Drug Production by Application (2024-2029) & (K Units)
Table 57. World CD20 Target Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World CD20 Target Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World CD20 Target Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World CD20 Target Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche CD20 Target Drug Product and Services
Table 64. Roche CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi CD20 Target Drug Product and Services
Table 70. Sanofi CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis CD20 Target Drug Product and Services
Table 76. Novartis CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. TG Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. TG Therapeutics Major Business
Table 81. TG Therapeutics CD20 Target Drug Product and Services
Table 82. TG Therapeutics CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. TG Therapeutics Recent Developments/Updates
Table 84. TG Therapeutics Competitive Strengths & Weaknesses
Table 85. AbbVie Basic Information, Manufacturing Base and Competitors
Table 86. AbbVie Major Business
Table 87. AbbVie CD20 Target Drug Product and Services
Table 88. AbbVie CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AbbVie Recent Developments/Updates
Table 90. AbbVie Competitive Strengths & Weaknesses
Table 91. Genmab Basic Information, Manufacturing Base and Competitors
Table 92. Genmab Major Business
Table 93. Genmab CD20 Target Drug Product and Services
Table 94. Genmab CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Genmab Recent Developments/Updates
Table 96. Genmab Competitive Strengths & Weaknesses
Table 97. PT Kalbe Genexine Biologics Basic Information, Manufacturing Base and Competitors
Table 98. PT Kalbe Genexine Biologics Major Business
Table 99. PT Kalbe Genexine Biologics CD20 Target Drug Product and Services
Table 100. PT Kalbe Genexine Biologics CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. PT Kalbe Genexine Biologics Recent Developments/Updates
Table 102. PT Kalbe Genexine Biologics Competitive Strengths & Weaknesses
Table 103. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Amgen, Inc. Major Business
Table 105. Amgen, Inc. CD20 Target Drug Product and Services
Table 106. Amgen, Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Amgen, Inc. Recent Developments/Updates
Table 108. Amgen, Inc. Competitive Strengths & Weaknesses
Table 109. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Pfizer Inc. Major Business
Table 111. Pfizer Inc. CD20 Target Drug Product and Services
Table 112. Pfizer Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pfizer Inc. Recent Developments/Updates
Table 114. Pfizer Inc. Competitive Strengths & Weaknesses
Table 115. Sandoz, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Sandoz, Inc. Major Business
Table 117. Sandoz, Inc. CD20 Target Drug Product and Services
Table 118. Sandoz, Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sandoz, Inc. Recent Developments/Updates
Table 120. Sandoz, Inc. Competitive Strengths & Weaknesses
Table 121. Celltrion, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. Celltrion, Inc. Major Business
Table 123. Celltrion, Inc. CD20 Target Drug Product and Services
Table 124. Celltrion, Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Celltrion, Inc. Recent Developments/Updates
Table 126. Celltrion, Inc. Competitive Strengths & Weaknesses
Table 127. Biocad Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Biocad Medical, Inc. Major Business
Table 129. Biocad Medical, Inc. CD20 Target Drug Product and Services
Table 130. Biocad Medical, Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Biocad Medical, Inc. Recent Developments/Updates
Table 132. Biocad Medical, Inc. Competitive Strengths & Weaknesses
Table 133. mAbxience SA Basic Information, Manufacturing Base and Competitors
Table 134. mAbxience SA Major Business
Table 135. mAbxience SA CD20 Target Drug Product and Services
Table 136. mAbxience SA CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. mAbxience SA Recent Developments/Updates
Table 138. mAbxience SA Competitive Strengths & Weaknesses
Table 139. Hetero Drugs Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Hetero Drugs Ltd. Major Business
Table 141. Hetero Drugs Ltd. CD20 Target Drug Product and Services
Table 142. Hetero Drugs Ltd. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Hetero Drugs Ltd. Recent Developments/Updates
Table 144. Hetero Drugs Ltd. Competitive Strengths & Weaknesses
Table 145. Aryogen Pharmed Basic Information, Manufacturing Base and Competitors
Table 146. Aryogen Pharmed Major Business
Table 147. Aryogen Pharmed CD20 Target Drug Product and Services
Table 148. Aryogen Pharmed CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Aryogen Pharmed Recent Developments/Updates
Table 150. Aryogen Pharmed Competitive Strengths & Weaknesses
Table 151. Biosidus SA Basic Information, Manufacturing Base and Competitors
Table 152. Biosidus SA Major Business
Table 153. Biosidus SA CD20 Target Drug Product and Services
Table 154. Biosidus SA CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Biosidus SA Recent Developments/Updates
Table 156. Biosidus SA Competitive Strengths & Weaknesses
Table 157. Probiomed SA de CV Basic Information, Manufacturing Base and Competitors
Table 158. Probiomed SA de CV Major Business
Table 159. Probiomed SA de CV CD20 Target Drug Product and Services
Table 160. Probiomed SA de CV CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Probiomed SA de CV Recent Developments/Updates
Table 162. Probiomed SA de CV Competitive Strengths & Weaknesses
Table 163. Henlius Basic Information, Manufacturing Base and Competitors
Table 164. Henlius Major Business
Table 165. Henlius CD20 Target Drug Product and Services
Table 166. Henlius CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Henlius Recent Developments/Updates
Table 168. Henlius Competitive Strengths & Weaknesses
Table 169. Innovent Basic Information, Manufacturing Base and Competitors
Table 170. Innovent Major Business
Table 171. Innovent CD20 Target Drug Product and Services
Table 172. Innovent CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Innovent Recent Developments/Updates
Table 174. Innovent Competitive Strengths & Weaknesses
Table 175. CHIATAI TIANOING Basic Information, Manufacturing Base and Competitors
Table 176. CHIATAI TIANOING Major Business
Table 177. CHIATAI TIANOING CD20 Target Drug Product and Services
Table 178. CHIATAI TIANOING CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. CHIATAI TIANOING Recent Developments/Updates
Table 180. CHIATAI TIANOING Competitive Strengths & Weaknesses
Table 181. CASI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 182. CASI Pharmaceuticals Major Business
Table 183. CASI Pharmaceuticals CD20 Target Drug Product and Services
Table 184. CASI Pharmaceuticals CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. CASI Pharmaceuticals Recent Developments/Updates
Table 186. CASI Pharmaceuticals Competitive Strengths & Weaknesses
Table 187. SinoCellTech Basic Information, Manufacturing Base and Competitors
Table 188. SinoCellTech Major Business
Table 189. SinoCellTech CD20 Target Drug Product and Services
Table 190. SinoCellTech CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. SinoCellTech Recent Developments/Updates
Table 192. BioRay Basic Information, Manufacturing Base and Competitors
Table 193. BioRay Major Business
Table 194. BioRay CD20 Target Drug Product and Services
Table 195. BioRay CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 196. Global Key Players of CD20 Target Drug Upstream (Raw Materials)
Table 197. CD20 Target Drug Typical Customers
Table 198. CD20 Target Drug Typical Distributors
LIST OF FIGURE
Figure 1. CD20 Target Drug Picture
Figure 2. World CD20 Target Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD20 Target Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CD20 Target Drug Production (2018-2029) & (K Units)
Figure 5. World CD20 Target Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World CD20 Target Drug Production Value Market Share by Region (2018-2029)
Figure 7. World CD20 Target Drug Production Market Share by Region (2018-2029)
Figure 8. North America CD20 Target Drug Production (2018-2029) & (K Units)
Figure 9. Europe CD20 Target Drug Production (2018-2029) & (K Units)
Figure 10. China CD20 Target Drug Production (2018-2029) & (K Units)
Figure 11. Japan CD20 Target Drug Production (2018-2029) & (K Units)
Figure 12. CD20 Target Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 15. World CD20 Target Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 17. China CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 22. India CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of CD20 Target Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CD20 Target Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CD20 Target Drug Markets in 2022
Figure 26. United States VS China: CD20 Target Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CD20 Target Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD20 Target Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CD20 Target Drug Production Market Share 2022
Figure 30. China Based Manufacturers CD20 Target Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CD20 Target Drug Production Market Share 2022
Figure 32. World CD20 Target Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CD20 Target Drug Production Value Market Share by Type in 2022
Figure 34. CD20 Target
Figure 35. CD20+CD3 Target
Figure 36. World CD20 Target Drug Production Market Share by Type (2018-2029)
Figure 37. World CD20 Target Drug Production Value Market Share by Type (2018-2029)
Figure 38. World CD20 Target Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World CD20 Target Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World CD20 Target Drug Production Value Market Share by Application in 2022
Figure 41. Rheumatoid Arthritis
Figure 42. Chronic Lymphocytic Leukemia
Figure 43. Lymphoma
Figure 44. Other
Figure 45. World CD20 Target Drug Production Market Share by Application (2018-2029)
Figure 46. World CD20 Target Drug Production Value Market Share by Application (2018-2029)
Figure 47. World CD20 Target Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. CD20 Target Drug Industry Chain
Figure 49. CD20 Target Drug Procurement Model
Figure 50. CD20 Target Drug Sales Model
Figure 51. CD20 Target Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World CD20 Target Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CD20 Target Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World CD20 Target Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World CD20 Target Drug Production Value Market Share by Region (2018-2023)
Table 5. World CD20 Target Drug Production Value Market Share by Region (2024-2029)
Table 6. World CD20 Target Drug Production by Region (2018-2023) & (K Units)
Table 7. World CD20 Target Drug Production by Region (2024-2029) & (K Units)
Table 8. World CD20 Target Drug Production Market Share by Region (2018-2023)
Table 9. World CD20 Target Drug Production Market Share by Region (2024-2029)
Table 10. World CD20 Target Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World CD20 Target Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. CD20 Target Drug Major Market Trends
Table 13. World CD20 Target Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World CD20 Target Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World CD20 Target Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World CD20 Target Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CD20 Target Drug Producers in 2022
Table 18. World CD20 Target Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key CD20 Target Drug Producers in 2022
Table 20. World CD20 Target Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global CD20 Target Drug Company Evaluation Quadrant
Table 22. World CD20 Target Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CD20 Target Drug Production Site of Key Manufacturer
Table 24. CD20 Target Drug Market: Company Product Type Footprint
Table 25. CD20 Target Drug Market: Company Product Application Footprint
Table 26. CD20 Target Drug Competitive Factors
Table 27. CD20 Target Drug New Entrant and Capacity Expansion Plans
Table 28. CD20 Target Drug Mergers & Acquisitions Activity
Table 29. United States VS China CD20 Target Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CD20 Target Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China CD20 Target Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based CD20 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CD20 Target Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CD20 Target Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CD20 Target Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers CD20 Target Drug Production Market Share (2018-2023)
Table 37. China Based CD20 Target Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CD20 Target Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CD20 Target Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CD20 Target Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers CD20 Target Drug Production Market Share (2018-2023)
Table 42. Rest of World Based CD20 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CD20 Target Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CD20 Target Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CD20 Target Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers CD20 Target Drug Production Market Share (2018-2023)
Table 47. World CD20 Target Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CD20 Target Drug Production by Type (2018-2023) & (K Units)
Table 49. World CD20 Target Drug Production by Type (2024-2029) & (K Units)
Table 50. World CD20 Target Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World CD20 Target Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World CD20 Target Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World CD20 Target Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World CD20 Target Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CD20 Target Drug Production by Application (2018-2023) & (K Units)
Table 56. World CD20 Target Drug Production by Application (2024-2029) & (K Units)
Table 57. World CD20 Target Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World CD20 Target Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World CD20 Target Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World CD20 Target Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche CD20 Target Drug Product and Services
Table 64. Roche CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi CD20 Target Drug Product and Services
Table 70. Sanofi CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis CD20 Target Drug Product and Services
Table 76. Novartis CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. TG Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. TG Therapeutics Major Business
Table 81. TG Therapeutics CD20 Target Drug Product and Services
Table 82. TG Therapeutics CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. TG Therapeutics Recent Developments/Updates
Table 84. TG Therapeutics Competitive Strengths & Weaknesses
Table 85. AbbVie Basic Information, Manufacturing Base and Competitors
Table 86. AbbVie Major Business
Table 87. AbbVie CD20 Target Drug Product and Services
Table 88. AbbVie CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AbbVie Recent Developments/Updates
Table 90. AbbVie Competitive Strengths & Weaknesses
Table 91. Genmab Basic Information, Manufacturing Base and Competitors
Table 92. Genmab Major Business
Table 93. Genmab CD20 Target Drug Product and Services
Table 94. Genmab CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Genmab Recent Developments/Updates
Table 96. Genmab Competitive Strengths & Weaknesses
Table 97. PT Kalbe Genexine Biologics Basic Information, Manufacturing Base and Competitors
Table 98. PT Kalbe Genexine Biologics Major Business
Table 99. PT Kalbe Genexine Biologics CD20 Target Drug Product and Services
Table 100. PT Kalbe Genexine Biologics CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. PT Kalbe Genexine Biologics Recent Developments/Updates
Table 102. PT Kalbe Genexine Biologics Competitive Strengths & Weaknesses
Table 103. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Amgen, Inc. Major Business
Table 105. Amgen, Inc. CD20 Target Drug Product and Services
Table 106. Amgen, Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Amgen, Inc. Recent Developments/Updates
Table 108. Amgen, Inc. Competitive Strengths & Weaknesses
Table 109. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Pfizer Inc. Major Business
Table 111. Pfizer Inc. CD20 Target Drug Product and Services
Table 112. Pfizer Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pfizer Inc. Recent Developments/Updates
Table 114. Pfizer Inc. Competitive Strengths & Weaknesses
Table 115. Sandoz, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Sandoz, Inc. Major Business
Table 117. Sandoz, Inc. CD20 Target Drug Product and Services
Table 118. Sandoz, Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sandoz, Inc. Recent Developments/Updates
Table 120. Sandoz, Inc. Competitive Strengths & Weaknesses
Table 121. Celltrion, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. Celltrion, Inc. Major Business
Table 123. Celltrion, Inc. CD20 Target Drug Product and Services
Table 124. Celltrion, Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Celltrion, Inc. Recent Developments/Updates
Table 126. Celltrion, Inc. Competitive Strengths & Weaknesses
Table 127. Biocad Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Biocad Medical, Inc. Major Business
Table 129. Biocad Medical, Inc. CD20 Target Drug Product and Services
Table 130. Biocad Medical, Inc. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Biocad Medical, Inc. Recent Developments/Updates
Table 132. Biocad Medical, Inc. Competitive Strengths & Weaknesses
Table 133. mAbxience SA Basic Information, Manufacturing Base and Competitors
Table 134. mAbxience SA Major Business
Table 135. mAbxience SA CD20 Target Drug Product and Services
Table 136. mAbxience SA CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. mAbxience SA Recent Developments/Updates
Table 138. mAbxience SA Competitive Strengths & Weaknesses
Table 139. Hetero Drugs Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Hetero Drugs Ltd. Major Business
Table 141. Hetero Drugs Ltd. CD20 Target Drug Product and Services
Table 142. Hetero Drugs Ltd. CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Hetero Drugs Ltd. Recent Developments/Updates
Table 144. Hetero Drugs Ltd. Competitive Strengths & Weaknesses
Table 145. Aryogen Pharmed Basic Information, Manufacturing Base and Competitors
Table 146. Aryogen Pharmed Major Business
Table 147. Aryogen Pharmed CD20 Target Drug Product and Services
Table 148. Aryogen Pharmed CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Aryogen Pharmed Recent Developments/Updates
Table 150. Aryogen Pharmed Competitive Strengths & Weaknesses
Table 151. Biosidus SA Basic Information, Manufacturing Base and Competitors
Table 152. Biosidus SA Major Business
Table 153. Biosidus SA CD20 Target Drug Product and Services
Table 154. Biosidus SA CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Biosidus SA Recent Developments/Updates
Table 156. Biosidus SA Competitive Strengths & Weaknesses
Table 157. Probiomed SA de CV Basic Information, Manufacturing Base and Competitors
Table 158. Probiomed SA de CV Major Business
Table 159. Probiomed SA de CV CD20 Target Drug Product and Services
Table 160. Probiomed SA de CV CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Probiomed SA de CV Recent Developments/Updates
Table 162. Probiomed SA de CV Competitive Strengths & Weaknesses
Table 163. Henlius Basic Information, Manufacturing Base and Competitors
Table 164. Henlius Major Business
Table 165. Henlius CD20 Target Drug Product and Services
Table 166. Henlius CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Henlius Recent Developments/Updates
Table 168. Henlius Competitive Strengths & Weaknesses
Table 169. Innovent Basic Information, Manufacturing Base and Competitors
Table 170. Innovent Major Business
Table 171. Innovent CD20 Target Drug Product and Services
Table 172. Innovent CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Innovent Recent Developments/Updates
Table 174. Innovent Competitive Strengths & Weaknesses
Table 175. CHIATAI TIANOING Basic Information, Manufacturing Base and Competitors
Table 176. CHIATAI TIANOING Major Business
Table 177. CHIATAI TIANOING CD20 Target Drug Product and Services
Table 178. CHIATAI TIANOING CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. CHIATAI TIANOING Recent Developments/Updates
Table 180. CHIATAI TIANOING Competitive Strengths & Weaknesses
Table 181. CASI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 182. CASI Pharmaceuticals Major Business
Table 183. CASI Pharmaceuticals CD20 Target Drug Product and Services
Table 184. CASI Pharmaceuticals CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. CASI Pharmaceuticals Recent Developments/Updates
Table 186. CASI Pharmaceuticals Competitive Strengths & Weaknesses
Table 187. SinoCellTech Basic Information, Manufacturing Base and Competitors
Table 188. SinoCellTech Major Business
Table 189. SinoCellTech CD20 Target Drug Product and Services
Table 190. SinoCellTech CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. SinoCellTech Recent Developments/Updates
Table 192. BioRay Basic Information, Manufacturing Base and Competitors
Table 193. BioRay Major Business
Table 194. BioRay CD20 Target Drug Product and Services
Table 195. BioRay CD20 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 196. Global Key Players of CD20 Target Drug Upstream (Raw Materials)
Table 197. CD20 Target Drug Typical Customers
Table 198. CD20 Target Drug Typical Distributors
LIST OF FIGURE
Figure 1. CD20 Target Drug Picture
Figure 2. World CD20 Target Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD20 Target Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CD20 Target Drug Production (2018-2029) & (K Units)
Figure 5. World CD20 Target Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World CD20 Target Drug Production Value Market Share by Region (2018-2029)
Figure 7. World CD20 Target Drug Production Market Share by Region (2018-2029)
Figure 8. North America CD20 Target Drug Production (2018-2029) & (K Units)
Figure 9. Europe CD20 Target Drug Production (2018-2029) & (K Units)
Figure 10. China CD20 Target Drug Production (2018-2029) & (K Units)
Figure 11. Japan CD20 Target Drug Production (2018-2029) & (K Units)
Figure 12. CD20 Target Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 15. World CD20 Target Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 17. China CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 22. India CD20 Target Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of CD20 Target Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CD20 Target Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CD20 Target Drug Markets in 2022
Figure 26. United States VS China: CD20 Target Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CD20 Target Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD20 Target Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CD20 Target Drug Production Market Share 2022
Figure 30. China Based Manufacturers CD20 Target Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CD20 Target Drug Production Market Share 2022
Figure 32. World CD20 Target Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CD20 Target Drug Production Value Market Share by Type in 2022
Figure 34. CD20 Target
Figure 35. CD20+CD3 Target
Figure 36. World CD20 Target Drug Production Market Share by Type (2018-2029)
Figure 37. World CD20 Target Drug Production Value Market Share by Type (2018-2029)
Figure 38. World CD20 Target Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World CD20 Target Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World CD20 Target Drug Production Value Market Share by Application in 2022
Figure 41. Rheumatoid Arthritis
Figure 42. Chronic Lymphocytic Leukemia
Figure 43. Lymphoma
Figure 44. Other
Figure 45. World CD20 Target Drug Production Market Share by Application (2018-2029)
Figure 46. World CD20 Target Drug Production Value Market Share by Application (2018-2029)
Figure 47. World CD20 Target Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. CD20 Target Drug Industry Chain
Figure 49. CD20 Target Drug Procurement Model
Figure 50. CD20 Target Drug Sales Model
Figure 51. CD20 Target Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
